AnPac Bio-Medical Science Co Gross Profit

AnPac Bio-Medical Science Co (ANPC) currently reports a gross profit of $8.3M as of December 2022. That compares with $12M in the prior-year period — down 32.0% year over year. That is below the Healthcare sector average of $67B. Use the charts on this page to explore AnPac Bio-Medical Science Co's gross profit history and peer comparisons.

AnPac Bio-Medical Science Co's gross profit decreased from $12M to $8.3M — a 32.0% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AnPac Bio-Medical Science Co's gross profit of $8.3M is lower than the Healthcare sector average of $67B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

AnPac Bio-Medical Science Co reported $8.3M in gross profit as of December 2022. That compares with $12M in the prior-year period — down 32.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $8.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $67B. From there, open related valuation or income-statement pages for AnPac Bio-Medical Science Co, and consider following ANPC for alerts when major investors trade the stock.